Regeneron Pharmaceuticals on Track for Largest Percent Decrease Since November 2023 — Data Talk
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $1152.64, down $26.73 or 2.27%
--Would be lowest close since Aug. 12, 2024, when it closed at $1121.09
--On pace for largest percent decrease since Nov. 9, 2023, when it fell 2.74%
--Currently down four of the past six days
--Up 31.24% year-to-date
--Down 4.09% from its all-time closing high of $1201.76 on Aug. 27, 2024
--Up 39.67% from 52 weeks ago (Sept. 7, 2023), when it closed at $825.26
--Down 4.09% from its 52-week closing high of $1201.76 on Aug. 27, 2024
--Up 48.69% from its 52-week closing low of $775.18 on Oct. 27, 2023
--Traded as low as $1143.24; lowest intraday level since Aug. 14, 2024, when it hit $1138.66
--Down 3.06% at today's intraday low; largest intraday percent decrease since Aug. 1, 2024, when it fell as much as 3.46%
--Seventh worst performer in the Nasdaq 100 today
--Eighth least active stock in the Nasdaq 100 today
All data as of 12:40:40 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 05, 2024 12:57 ET (16:57 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks